| scholarly article | Q13442814 |
| P50 | author | Sanjay H. Chotirmall | Q37829363 |
| Mazen Al-Alawi | Q59259794 | ||
| P2093 | author name string | T Hassan | |
| N G McElvaney | |||
| P2860 | cites work | Diagnostic accuracy of pleural fluid NT-pro-BNP for pleural effusions of cardiac origin: a systematic review and meta-analysis | Q21257189 |
| Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions | Q28238665 | ||
| A systematic review of rapid diagnostic tests for the detection of tuberculosis infection | Q28285993 | ||
| Diagnosis and treatment of tuberculous pleural effusion in 2006. | Q30360413 | ||
| The diagnostic role of glycosaminoglycans in pleural effusions: a pilot study | Q33410381 | ||
| Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting | Q33416753 | ||
| Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels | Q33897209 | ||
| Does pleural fluid appearance really matter? The relationship between fluid appearance and cytology, cell counts, and chemical laboratory measurements in pleural effusions of patients with cancer | Q34105039 | ||
| The serum-effusion albumin gradient in the evaluation of pleural effusions | Q34180976 | ||
| Pleural effusions: the diagnostic separation of transudates and exudates | Q34215688 | ||
| Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions | Q81134367 | ||
| Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria | Q81308712 | ||
| Diagnostic value of complement components in pleural fluid: report of 135 cases | Q81696015 | ||
| Prognostic significance of carcinoembryonic antigen level in pleural lavage fluid for patients with lung adenocarcinoma | Q81884201 | ||
| A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion | Q82650314 | ||
| Diagnostic value of leptin in tuberculous pleural effusions | Q83275320 | ||
| Incidence and aetiology of eosinophilic pleural effusion | Q83704937 | ||
| Reappraisal of the standard method (Light's criteria) for identifying pleural exudates | Q34498596 | ||
| Rheumatoid pleural effusion | Q34536692 | ||
| Chylothorax and cholesterol pleural effusion | Q34626198 | ||
| Volume of pleural fluid required for diagnosis of pleural malignancy | Q35022244 | ||
| Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis | Q35200811 | ||
| Etiology and pleural fluid characteristics of large and massive effusions | Q35217209 | ||
| Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma | Q36225781 | ||
| Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis | Q37068247 | ||
| Tuberculous pleural effusion | Q37578334 | ||
| The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. | Q37668503 | ||
| Prospective study to determine the volume of pleural fluid required to diagnose malignancy | Q38379111 | ||
| Parasitic infections of the pleural space | Q39402161 | ||
| Antinuclear antibody testing in pleural fluid for the diagnosis of lupus pleuritis | Q40174044 | ||
| Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-gamma in pleural fluid for the differential diagnosis of pleural tuberculosis | Q40611982 | ||
| Serial antinuclear antibodies titre in pleural and pericardial fluid | Q40869562 | ||
| Determination of total proteins and lactate dehydrogenase for the diagnosis of pleural transudates and exudates: redefining the classical criterion with a new statistical approach | Q42909619 | ||
| Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients | Q42917860 | ||
| Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure | Q43638214 | ||
| Useful tests on pleural fluid that distinguish transudates from exudates | Q43815118 | ||
| Comparative analysis of Light's criteria and other biochemical parameters to distinguish exudates from transudates | Q43952276 | ||
| Prevalence of benign disease in patients undergoing resection for suspected lung cancer | Q44007746 | ||
| Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma | Q44125897 | ||
| Biomarkers of infection for the differential diagnosis of pleural effusions. | Q45961021 | ||
| Diagnostic value of interleukin-12 p40 in tuberculous pleural effusions. | Q46220352 | ||
| High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation | Q46317410 | ||
| Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions | Q46806322 | ||
| Utility of quantitative T-cell responses versus unstimulated interferon-{gamma} for the diagnosis of pleural tuberculosis. | Q47961867 | ||
| Clinical implications of appearance of pleural fluid at thoracentesis | Q48032537 | ||
| The importance of pleural fluid and serum NT-proBNP levels in differentiating pleural effusion due to heart failure from other causes of effusion | Q48720330 | ||
| Immunocytochemical identification of carcinomas of unknown primary in serous effusions. | Q51961784 | ||
| Diagnostic value of proinflammatory interleukins in parapneumonic effusions. | Q53323904 | ||
| High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions | Q57531305 | ||
| Soluble Mesothelin–related Peptides in the Diagnosis of Malignant Pleural Mesothelioma | Q57554489 | ||
| Diagnostic Utility of Serum and Pleural Fluid Carcinoembryonic Antigen, Neuron-Specific Enolase, and Cytokeratin 19 Fragments in Patients With Effusions From Primary Lung Cancer | Q58198360 | ||
| Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications | Q59111644 | ||
| Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions | Q59274557 | ||
| Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies | Q60473171 | ||
| Discrimination of exudative pleural effusions based on multiple biological parameters | Q61510857 | ||
| Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions | Q67874661 | ||
| Neopterin in tuberculous and neoplastic pleural fluids | Q68174964 | ||
| Pleural fluid to serum bilirubin concentration ratio for the separation of transudates from exudates | Q68833227 | ||
| Cholesterol in pleural effusions. A diagnostic aid | Q69125793 | ||
| Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma | Q70558477 | ||
| Pleural fluid interferon-gamma and tumour necrosis factor-alpha in tuberculous and rheumatoid pleurisy | Q71674544 | ||
| Tumour necrosis factor-alpha and nitric oxide, determined as nitrite, in malignant pleural effusion | Q72521869 | ||
| Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis | Q73653055 | ||
| Comparative analysis of biochemical parameters for differentiation of pleural exudates from transudates Light's criteria, cholesterol, bilirubin, albumin gradient, alkaline phosphatase, creatine kinase, and uric acid | Q73688341 | ||
| Use of pleural fluid C-reactive protein in diagnosis of pleural effusions | Q73928526 | ||
| Complement components and their activation products in pleural fluid | Q77318681 | ||
| Tuberculous pleurisy: a study of 254 patients | Q77430839 | ||
| Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions | Q77753846 | ||
| Is it meaningful to use biochemical parameters to discriminate between transudative and exudative pleural effusions? | Q78500232 | ||
| Acute phase markers for the differentiation of infectious and malignant pleural effusions | Q79707244 | ||
| Contribution of a pleural antigen assay (Binax NOW) to the diagnosis of pneumococcal pneumonia | Q79818592 | ||
| Diagnostic value of pleural fluid N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases | Q80498668 | ||
| Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion | Q80854627 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 716235 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | Pulmonary Medicine | Q26842234 |
| P1476 | title | Pleural fluid analysis: standstill or a work in progress? | |
| P478 | volume | 2012 |
| Q47652002 | Diagnostic Value of Vascular Endothelial Growth Factor, Transforming Growth Factor-β, Interleukin-8, and the Ratio of Lactate Dehydrogenase to Adenosine Deaminase in Pleural Effusion. |
| Q36247822 | Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature |
| Q91992619 | Laboratory testing of extravascular body fluids: National recommendations on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Part I - Serous fluids |
| Q37607314 | Pleural, peritoneal and pericardial effusions - a biochemical approach |
| Q40693331 | Reactive oxygen species measure for rapid detection of infection in fluids |
| Q39063366 | Systematic review and meta-analysis of vascular endothelial growth factor as a biomarker for malignant pleural effusions. |
Search more.